Health · 1 view
Weekly cisplatin fails to show fewer serious side effects in p16-negative head and neck cancer
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer.
Summary
Physicians typically use either a higher dose of cisplatin given every three weeks or a lower dose given weekly in combination with radiation to treat locally advanced head and neck cancer. However, before NRG-HN009, there was limited randomized evidence to determine which regimen provided the best balance of cancer control and treatment-related side effects.
AI summaries can be wrong sometimes—always verify important details using the source article.
How AI & Automation are usedMore from Health
Continue reading recent Health coverage
- Alan Alda on fighting Parkinson's with laughterContinue reading
- Medicare for All remains key pressure point for Democrats ahead of midtermsContinue reading
- Book excerpt: "Narratives" by Nancy ColierContinue reading
- Polyubiquitin may stabilize tau filament structures in neurodegenerative diseasesContinue reading
Support HappeningNow
Independent AI-powered news analysis is reader-supported. Your contribution helps cover infrastructure, summaries, and continued platform development.
Support HappeningNow